Document Detail


Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
MedLine Citation:
PMID:  12555159     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: A major advance in understanding the pathophysiology of the heart failure syndrome has been an understanding of the process of left ventricular (LV) remodeling. After any insult to the left ventricle resulting in diminished systolic performance and stroke volume, a series of histopathologic changes in the myocardium and structural changes in the LV chamber occurs over time. METHODS AND RESULTS: Early work on understanding this process of LV remodeling emerged from the studies of Pfeffer and colleagues, who used a rat model of myocardial infarction (MI). Compared to those with smaller MIs, rats with larger induced MIs underwent a substantially greater degree of chamber remodeling over time, and importantly, these structural changes were associated with significantly higher morality. These studies established for the first time the relation between the structural changes now widely known as LV remodeling and a natural history outcome in the setting of LV systolic dysfunction. Subsequently, these investigators demonstrated that angiotensin-converting enzyme (ACE) inhibition with captopril, when initiated soon after the induced MI, attenuated the remodeling process. Also observed was an improvement in survival among rats in whom the remodeling process has been attenuated. These important data paved the way for human studies that have subsequently provided substantial evidence to support two important concepts: (1) that LV remodeling is related to clinical outcomes that represent the natural history of the heart failure syndrome such as mortality and surrogate markers of the progression of heart failure, and (2) that therapeutic interventions in humans that slow or reverse the process of LV remodeling, such as ACE inhibitors and beta-blockers, appear to have a favorable effect on that natural history. CONCLUSIONS: This review will examine the issue of the relation between LV remodeling and clinical outcomes in the human heart failure syndrome from several interrelated aspects: (1) the relation between LV volume at one time point and subsequent oucome, (2) the relation between changes in LV volumes over time (LV remodeling) and clinical outcomes, and (3) the relation between the effect of medical therapeutic interventions on the LV remodeling process and the effect of those same medical interventions on natural history outcomes in human heart failure.
Authors:
James E Udelson; Marvin A Konstam
Related Documents :
3227889 - Dynamics of the interventricular septum and ventricular free walls during regional isch...
16894269 - Systolic dysfunction: correlation of acoustic cardiography with doppler echocardiography.
17532519 - Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside rg1, ...
20473009 - The influence of left ventricular diameter on left atrial appendage size and thrombus f...
16449509 - Role of regional mechanical dyssynchrony as a determinant of functional mitral regurgit...
15472639 - Incremental prognostic value of left ventricular function by myocardial ecg-gated fdg p...
23049079 - Cardiac transplantation for spontaneous coronary artery dissection.
8732379 - Differences of disease progression in congestive heart failure due to alcoholic as comp...
18507539 - Quality of ecg monitoring with a miniature ecg recorder.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of cardiac failure     Volume:  8     ISSN:  1071-9164     ISO Abbreviation:  J. Card. Fail.     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2003-01-29     Completed Date:  2003-04-08     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9442138     Medline TA:  J Card Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S465-71     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Animals
Heart Failure / drug therapy,  physiopathology*
Humans
Rats
Systole / physiology
Time Factors
Ventricular Dysfunction, Left / physiopathology*
Ventricular Remodeling*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Noninvasive assessment of left ventricular remodeling: concepts, techniques, and implications for cl...
Next Document:  The dog model of left ventricular remodeling after myocardial infarction.